|
1
| 1 | INTERNATIONAL COMPETITION POLICY ADVISORY COMMITTEE
|
| 2 | HEARINGS
|
| 3 |
|
| 4 |
|
| 5 |
|
| 6 | Washington, D.C.
|
| 7 | April 22, 1999
|
| 8 |
|
| 9 |
|
| 10 |
|
| 11 |
|
| 12 |
|
| 13 | This document constitutes accurate minutes of the
|
| 14 | meeting held April 22, 1999 by the International
|
| 15 | Competition Policy Advisory Committee. It has been
|
| 16 | edited for transcription errors.
|
| 17 |
|
| 18 |
|
| 19 |
|
| 20 |
|
| 21 |
|
| 22 |
|
| 23 | |
2
| 1 | INTERNATIONAL COMPETITION POLICY ADVISORY COMMITTEE
|
| 2 | HEARINGS
|
| 3 |
|
| 4 |
|
| 5 |
|
| 6 | Washington, D.C.
|
| 7 | April 22, 1999
|
| 8 |
|
| 9 |
|
| 10 |
|
| 11 |
|
| 12 |
|
| 13 |
|
| 14 | Taken at the Center for Strategic and International Studies, 1800 K
|
| 15 | Street, N.W., B-1 Conference Center, Washington, D.C., beginning at 9:00
|
| 16 | A.M., before Ann Marie Federico, a court reporter and notary public in and for
|
| 17 | the District of Columbia.
|
| 18 |
|
| 19 |
|
| 20 |
|
| 21 |
|
| 22 |
|
| 23 | |
3
| 1 | APPEARANCES
|
| 2 | Advisory Committee Members:
|
| 3 | James F. Rill, Co-Chair and Senior Partner, Collier, Shannon, Rill & Scott,
|
| 4 | PLLC
|
| 5 | Paula Stern, Co-Chair and President, The Stern Group, Inc.
|
| 6 | Merit E. Janow, Executive Director and Professor in the Practice of
|
| 7 | International Trade, School of International and Public Affairs,
|
| 8 | Columbia University
|
| 9 | Thomas E. Donilon, Partner, O'Melveny & Myers
|
| 10 | John T. Dunlop, Lamont University Professor, Emeritus, Harvard
|
| 11 | University
|
| 12 | Eleanor M. Fox,Walter Derenberg Professor of Trade Regulation,
|
| 13 | New York University School of Law
|
| 14 | Department of Justice Employees:
|
| 15 | Joel I. Klein, Assistant Attorney General, Antitrust Division
|
| 16 | Other:
|
| 17 | Debra Valentine, General Counsel, Federal Trade Commission
|
| 18 | Members of the Public Appearing before the Advisory Committee and Presenting Written or
|
| 19 | Oral Statements:
|
| 20 | Panelists: Confidential Information Sharing:
|
| 21 | Klaus F. Becher, Associate General Counsel, DaimlerChrysler AG
|
| 22 | A. Neil Campbell, McMillan Binch
|
| 23 | Janet L. McDavid, Hogan & Hartson LLP |
4
| 1 | Panelists: Confidential Information Sharing (cont'd.)
|
| 2 | Phillip A. Proger, Jones, Day, Reavis & Pogue
|
| 3 | Panelists: Representatives of Trade Associations:
|
| 4 | American Forest & Paper Association - Maureen R. Smith, Vice President,
|
| 5 | International
|
| 6 | The Business Roundtable - Robert C. Weinbaum, Assistant General Counsel,
|
| 7 | General Motors Corporation ; Thomas B. Leary, Hogan & Hartson, LLP
|
| 8 | National Association of Manufacturers - Stephen Bolerjack, Counsel,
|
| 9 | Antitrust and Trade Regulation, Ford Motor Company
|
| 10 | U.S. Chamber of Commerce - William Blumenthal, King & Spalding
|
| 11 | U.S. Council for International Business - Thomas M. T. Niles, President
|
| 12 | Panelists: The Role of International Institutions in Competition Policy:
|
| 13 | Joe Phillips, Organization for Economic Cooperation and Development
|
| 14 | Mark A. A. Warner, Organization for Economic Cooperation and
|
| 15 | Development
|
| 16 | Panelists: The International Antitrust Law Committee of the ABA Section of
|
| 17 | International Law and Practice:
|
| 18 | Donald I. Baker, Baker & Miller PLLC
|
| 19 | Michael H. Byowitz, Wachtell, Lipton, Rosen & Katz
|
| 20 | Paul S. Crampton, Davies, Ward & Beck
|
| 21 | Daryl A. Libow, Sullivan & Cromwell
|
| 22 |
|
| 23 | |
5
| 1 | IN ATTENDANCE:
|
| 2 | Advisory Committee Staff:
|
| 3 | Cynthia R. Lewis, Counsel
|
| 4 | Andrew J. Shapiro, Counsel
|
| 5 | Stephanie G. Victor, Counsel
|
| 6 | Eric J. Weiner, Paralegal
|
| 7 | Estimated number of members of the public in attendance: 30
|
| 8 | Reports or Other Documents Received, Issued, or Approved by the Advisory
|
| 9 | Committee:
|
| 10 | International Bar Association Exchanges of Confidential Information
|
| 11 | Between Antitrust Enforcement Agencies, Preliminary Observations
|
| 12 | Prepared by a Working Group of the Antitrust and Trade Committee
|
| 13 | of the International Bar Association
|
| 14 | International Chamber of Commerce ICC recommendations to the
|
| 15 | International Competition Policy Advisory Committee (ICPAC) on
|
| 16 | exchange of confidential information between competition authorities in
|
| 17 | the merger context, prepared by the Commission on Law and Practices
|
| 18 | Relating to Competition
|
| 19 | American Forest & Paper Association Presentation by Maureen R. Smith,
|
| 20 | Vice President, International, American Forest & Paper Association
|
| 21 | The Business Roundtable Statement of Robert C. Weinbaum, Office of
|
| 22 | General Counsel, General Motors Corporation, on behalf of The
|
| 23 | Business Roundtable Task Forces on International Trade and Investment |
6
| 1 | and on Government Regulation
|
| 2 | National Association of Manufacturers Testimony of Stephen D. Bolerjack,
|
| 3 | Counsel, Antitrust and Trade Regulation, Ford Motor Company, on
|
| 4 | behalf of the National Association of Manufacturers
|
| 5 | U.S. Chamber of Commerce Comments of the U.S. Chamber of Commerce
|
| 6 | United States Council for International Business Comments of the United
|
| 7 | States Council for International Business (USCIB) on International
|
| 8 | Competition Issues to the International Competition Policy Advisory
|
| 9 | Committee, May 27, 1999; Preliminary Comments (Oral Statement) of
|
| 10 | Ambassador Thomas M. T. Niles, President, USCIB
|
| 11 | OECD Speech by Joanna R. Shelton, Deputy Secretary-General, OECD,
|
| 12 | "Competition Policy: What Chance for International Rules?" (Nov. 25,
|
| 13 | 1998), submitted by Bernard Phillips
|
| 14 | ABA Section of International Law and Practice presentation by Members of
|
| 15 | the International Antitrust Law Committee (Don Baker, Mike Byowitz,
|
| 16 | Paul Crampton and Daryl Libow)
|
| 17 |
|
| 18 |
|
| 19 |
|
| 20 |
|
| 21 |
|
| 22 |
|
| 23 | |
7
| 1 | PROCEEDINGS
|
| 2 | MR. RILL: Let me welcome everyone to the April 22 hearings
|
| 3 | of the International Competition Policy Advisory Committee and express my
|
| 4 | thanks to those of you who will be appearing today, and to the press and others
|
| 5 | in the audience. This is actually the second wave of hearings. We also had a
|
| 6 | hearing scheduled for tomorrow but were ousted by the crowds of the 50th
|
| 7 | anniversary of the North Atlantic Treaty Organization. A few of us in the
|
| 8 | room remember when that was signed.
|
| 9 | The Committee's hearings today were really prompted by a
|
| 10 | number of very thoughtful papers and views that have been presented to us.
|
| 11 | Also, they have been prompted by exchanges at the last hearings -- those
|
| 12 | hearings took place in November and focused on a variety of issues that are
|
| 13 | going to be discussed and illuminated today.
|
| 14 | Today's hearings will progress with four separate sessions.
|
| 15 | Session 1 on confidential information sharing; Session 2 on presentations by
|
| 16 | various representatives of trade associations which have been particularly
|
| 17 | knowledgeable and interested in the work of the Advisory Committee; Session
|
| 18 | 3, which now has become basically an OECD session -- we at our November
|
| 19 | hearings had participation by a number of governments interested in the
|
| 20 | merger, trade and competition and enforcement cooperation areas. Today we
|
| 21 | will hear from two representatives of OECD -- representing 29 governments --
|
| 22 | and finally Session 4, a presentation by the representatives of the International
|
| 23 | Law and Practice Committee of the American Bar Association, which has met |
8
| 1 | with us on a couple of occasions and done a great deal of work in this area.
|
| 2 | Before recognizing the first panel, I would like to acknowledge
|
| 3 | the Committee members who are present: John Dunlop, Eleanor Fox, and my
|
| 4 | Co-Chair, Paula Stern, and our erudite and extraordinarily competent leader,
|
| 5 | Executive Director Merit Janow.
|
| 6 | Again, before recognizing the first panel, I would like to call on
|
| 7 | Paula for any introductory comments she may have and then turn it over to
|
| 8 | Assistant Attorney General Klein, who is the father of this effort.
|
| 9 | DR. STERN: I would like to just second the welcome to
|
| 10 | everybody, particularly those who have come from so very far, and say that we
|
| 11 | are closing in on a number of the issues. We feel we have made an enormous
|
| 12 | amount of progress thanks to the input of individuals like yourselves. Your
|
| 13 | individual input has been extremely valuable and I am looking forward to a
|
| 14 | very fruitful day, and of course on May 17th we will resume the hearings that
|
| 15 | we have postponed that had been scheduled for tomorrow. And I am now
|
| 16 | looking forward to hearing from the father of the Committee, Joel Klein.
|
| 17 | MR. KLEIN: Thank you. It's often been said that victory has
|
| 18 | many parents and defeat is an orphan. I am happy to have sired this enterprise.
|
| 19 | I hope I feel that way on the day the final report comes out. For the time
|
| 20 | being, actually this really was the Attorney General's ultimate decision and she
|
| 21 | deserves a great deal of credit, because I am sure there were a number of
|
| 22 | people out there who said to her as they said to me: Well, why would you
|
| 23 | unleash at least a dozen people who are not in your employ, and who are |
9
| 1 | independent and tough-minded people with a lot of knowledge and background
|
| 2 | in this area to go out and make a report that will tell the Department all sorts
|
| 3 | of things that it ought to be doing with respect to international antitrust
|
| 4 | enforcement?
|
| 5 | I think it reflects, truly, her sense of security and her willingness
|
| 6 | to reach out to some of the finest, most talented people in the field to bring in
|
| 7 | recommendations in an area in which, frankly, there are not easy and obvious
|
| 8 | answers. And I think it's not typical in government to go out and put this much
|
| 9 | responsibility and this much power, frankly, in the hands of an advisory
|
| 10 | committee.
|
| 11 | Everything I have seen about the process confirms to me that the
|
| 12 | judgment that the Attorney General made was right. The hearings that were
|
| 13 | held last fall, I think, were really landmark hearings. The bound transcript
|
| 14 | that's come out of that is a document in and of itself worthy of careful
|
| 15 | attention and study. And I anticipate the report we're going to get later this
|
| 16 | year from this Committee is going to be really a true landmark report in the
|
| 17 | issues of globalization of antitrust enforcement, and the intersection of trade
|
| 18 | and competition policy.
|
| 19 | Let me tell you, it could not come at a more timely point in our
|
| 20 | history. Even as the Committee does its work, this area keeps growing and
|
| 21 | exploding. You wake up this morning and you see the proposed merger
|
| 22 | between Deutsche Telekom and Telecom Italia. And that is simply a harbinger
|
| 23 | of what we are going to see in the next five to ten years. People who do not |
10
| 1 | think we are going to see a spectacular increase in global mergers along the
|
| 2 | lines of these $50-$100 billion-plus deals in the next four to five years should
|
| 3 | not be allowed to go online by themselves during day trading.
|
| 4 | (Laughter)
|
| 5 | This is as obvious as it is compelling. It's going to raise some
|
| 6 | very, very complicated issues. I am sure, as we sit here now, people
|
| 7 | throughout the world are thinking about the implications of this particular
|
| 8 | merger and, indeed, what it does to the ongoing relationships between Sprint
|
| 9 | and Deutsche Telekom, and France Telecom, a transaction that the Division
|
| 10 | actually reviewed and conditioned when it originally took place.
|
| 11 | Beyond this merger boom that we currently see and will continue
|
| 12 | to see, I cannot tell you because it's confidential, but I can indicate something
|
| 13 | about the nature of the Division's work in cartel enforcement, international
|
| 14 | cartel enforcement. Again, this reflects truly a sea change in antitrust
|
| 15 | enforcement. The nations of the world have come several standard deviations
|
| 16 | in terms of their levels of cooperation between what we saw in 1993 and '94,
|
| 17 | when we did the DeBeers/GE cartel case, to what we're seeing now. And it's
|
| 18 | frequently been reported that we have somewhere around 30 active grand juries
|
| 19 | looking into international cartels. What's not as well known is the magnitude
|
| 20 | of the volumes of commerce that are affected by these price-fixed industries.
|
| 21 | And for those of you who often hear in academic debates
|
| 22 | questions about whether there is a need or not a need for antitrust enforcement,
|
| 23 | the fact that this could be debated anywhere proves to me that there is not |
11
| 1 | enough reports going on in the academies. But when you think about this and
|
| 2 | look at the fact that, with effective global worldwide antitrust enforcement,
|
| 3 | there are at a minimum, I believe, 20 or 30 huge ongoing international cartel
|
| 4 | conspiracies that are taking, I believe, billions of dollars annually out of the
|
| 5 | U.S. economy, the need to be as effective in the international setting as we are
|
| 6 | in the domestic setting is absolutely critical. And the work of this Committee
|
| 7 | will obviously have an impact on that as well.
|
| 8 | And finally, it could hardly be more timely in terms of the issues
|
| 9 | at the intersection of trade and competition policy -- which I will tell you are
|
| 10 | some of the most difficult and sensitive issues both in terms of thinking
|
| 11 | through the policy and, indeed, of thinking through the politics. And I will
|
| 12 | look forward to the report of the Committee in that respect.
|
| 13 | In the meantime, we have now got actually our first at least
|
| 14 | partial result of our first positive comity referral on the computer reservation
|
| 15 | system that we referred to Europe -- to DG-IV -- with respect to Sabre's
|
| 16 | concerns about market access in Europe. At this point, DG-IV has issued a
|
| 17 | statement of objections that is a kind of Notice of Proposed Finding of
|
| 18 | Violation to Air France. In the meantime, Sabre has resolved its disputes in
|
| 19 | terms of the private negotiations with respect to Lufthansa and SAS, all of
|
| 20 | which suggest that positive comity can be and will be a modest but important
|
| 21 | player in the issues at the intersection of trade and competition policy.
|
| 22 | At the same time it's obviously essential, from our point of view,
|
| 23 | that competition policy remain soundly based in key antitrust economic |
12
| 1 | principles and that the issues at the border of trade and competition policy not
|
| 2 | be clouded in any way that undermines or erodes effective antitrust
|
| 3 | enforcement. In that regard, we're looking toward the end of this year to
|
| 4 | another round at the World Trade Organization. And while there will be a
|
| 5 | wide variety, I'm sure, of different views, for the United States I think this is
|
| 6 | really one time where the Goldilocks policy -- which is we don't want it to be
|
| 7 | too cold or too hot -- is going to be a critical balance.
|
| 8 | And what I mean by that is, I think it is very important that the
|
| 9 | WTO keep a key oar as probably, in many respects, the most inclusive global
|
| 10 | organization that will be looking at the range of issues at the intersection of
|
| 11 | trade and competition. I think they have got to remain a key player in this
|
| 12 | evolving process which I think we have to take a long-term view about. And at
|
| 13 | the same time I don't think they are ready for dispute resolution. And so, what
|
| 14 | I want to make sure is that we both continue to empower the WTO efforts in
|
| 15 | this area while at the same time we don't prematurely reach some model of
|
| 16 | dispute resolution or hard negotiations which could in the end do more harm
|
| 17 | than good. So that will be a role that we will play, I believe, aggressively. Of
|
| 18 | course, we will await the recommendations of this Advisory Committee as we
|
| 19 | continue to refine our thinking in detail in all of these areas.
|
| 20 | I just want to leave -- this is actually a little longer than I
|
| 21 | typically do this, because last week I had to sit and listen while all these people
|
| 22 | associated with the American Bar Association spoke at their annual Spring
|
| 23 | meeting, so I figured this is my shot to make them sit and listen while I speak. |
13
| 1 | But none was more eloquent than Phil, who had to try to manage 2,000 people
|
| 2 | who had, it seemed to me, each gone to about 2,000 cocktail parties before they
|
| 3 | showed up. He handled it. He said, in one of the lines that will sort of live
|
| 4 | forever, he said, "We're going to introduce the front table, and I would ask
|
| 5 | only one thing, that you hold your applause until the end." And what
|
| 6 | everybody on the front table said is, you should ask only one thing, "Would
|
| 7 | you be kind enough at least to applaud?" I think you managed some success in
|
| 8 | that.
|
| 9 | But I close by telling you that, actually, I think as we move
|
| 10 | forward, the need for the work of this Committee, the thoughtful engagement
|
| 11 | that is likely to grow out of the enormously fine work that has occurred, is so
|
| 12 | critical now that, whatever else, I will credit the Attorney General not just for
|
| 13 | her foresight but for her brilliance in timing. Because this is the right time for
|
| 14 | this report. Let me again thank you Jim, Paula, the members of the Committee,
|
| 15 | and also Merit and the members of her staff, who have just done a terrific
|
| 16 | amount of very, very good work. I am personally much in your debt and I'm
|
| 17 | sure the Attorney General shares that as well. Thank you.
|
| 18 | MR. RILL: Joel, thanks very much. We are personally very
|
| 19 | much in your debt for the support and leadership you have given us, as well as
|
| 20 | the resources that we have available to us, a truly superb staff. Cynthia
|
| 21 | Lewis, Andrew Shapiro, and Stephanie Victor, who work tirelessly to develop
|
| 22 | papers and think-pieces for our input. And also as a matter of my own
|
| 23 | observation privilege, Sarah Bauers of our firm, who also has contributed an |
14
| 1 | enormous amount of time and insight into this project.
|
| 2 | With that, we'll just turn to the first panel. At our last hearings
|
| 3 | there was a great deal of discussion on the issues related to the sharing of
|
| 4 | confidential information which is necessarily implicated in all of the subjects
|
| 5 | that we're dealing with: mergers, trade and competition, and cartel enforcement
|
| 6 | cooperation. And interest was expressed by the Committee members and by
|
| 7 | the panelists in having a more detailed exploration of those issues. So today
|
| 8 | we have representatives of three organizations that volunteered, I will use that
|
| 9 | term advisedly, to present papers and views on the issue of confidential
|
| 10 | information.
|
| 11 | The IBA group is represented by Neil Campbell, of McMillan
|
| 12 | Binch in Toronto, an award-winning student, an award-winning professor, the
|
| 13 | Rapporteur of the Global Forum, and if you don't know what that is, you need
|
| 14 | to read some of his papers, which are truly excellent. Let me commend a
|
| 15 | recent paper that was put out on international merger control, the recent book
|
| 16 | that was put out on international merger control by the Global Forum.
|
| 17 | The ICC, International Chamber of Commerce, will be
|
| 18 | represented by Klaus Becher, who is associate general counsel for
|
| 19 | DaimlerChrysler. Klaus has been in the antitrust world for 15 years, is a
|
| 20 | member of the ICC's Commission on Competition, and is head of a task force
|
| 21 | of the International Chamber of Commerce that was put together to present
|
| 22 | views to us on this subject.
|
| 23 | The third presentation is a panel of the leadership of the |
15
| 1 | Antitrust Section of the American Bar Association. Let me emphasize that
|
| 2 | today they're speaking for themselves based on their enormous expertise and
|
| 3 | not expressing the view of the American Bar Association, the Antitrust
|
| 4 | Section, and possibly their partners. But I can only say that having been
|
| 5 | through the bureaucracy of the American Bar Association, we understand that
|
| 6 | position fully and are delighted to have the views of such expert panelists.
|
| 7 | Phil Proger, of Jones Day Reavis & Pogue, the current chair of
|
| 8 | the Antitrust Section, and a longtime practitioner in antitrust, is one of our
|
| 9 | panelists of ABA Antitrust Section leaders. And the other is Jan McDavid, of
|
| 10 | Hogan & Hartson, who is the incoming chair of the ABA Section of Antitrust
|
| 11 | Law. I'm privileged to have worked and known both of them as friends and
|
| 12 | respected colleagues for more years than probably any of the three of us care
|
| 13 | to think. But they bring to this panel a unique expertise in international
|
| 14 | mergers, trade and competition, and enforcement issues.
|
| 15 | So without introducing each, take the time you need to give us
|
| 16 | your views and if it's agreeable we'll save the questions until all the panelists
|
| 17 | are through. So, Neil, if we may start with you. Actually, Neil, I'll reverse
|
| 18 | that for a minute because I understand Jan has to leave. You don't? Okay.
|
| 19 | Then we'll save the questions to the end. And Neil, if we could have your
|
| 20 | views, then go to Klaus and Phil and Jan.
|
| 21 | MR. CAMPBELL: Jim, thank you very much for the kind
|
| 22 | introduction. And good morning to you, and all the Committee members and
|
| 23 | guests. It's a great honor and privilege to come and speak to this group, |
16
| 1 | particularly when we hear the Assistant Attorney General explaining what he
|
| 2 | thinks the significance of the work of this Committee is.
|
| 3 | And, Jim, as you have said, the history leading to us being here
|
| 4 | this morning is some discussion about information-sharing issues at the
|
| 5 | November Advisory Committee hearings. And I can say on behalf of the
|
| 6 | International Bar Association, the IBA, that they very much appreciated the
|
| 7 | invitation to provide input into that process. And what the IBA has done
|
| 8 | through its Antitrust and Trade Committee is strike a small working group. I
|
| 9 | think I have to make the same caveat that you made for others, and that is that
|
| 10 | what you will hear this morning are the views of the working group of three,
|
| 11 | which have not gone through the protocols of an IBA formal policy statement
|
| 12 | approval.
|
| 13 | My colleagues in the working group are Terry Calvani, of the
|
| 14 | Pillsbury, Madison firm, who I think is well known to many people here, and
|
| 15 | had hoped to be with us this morning but has been called away and asked me to
|
| 16 | give his regrets. And John Davies, from the Freshfields firm in Brussels, who
|
| 17 | was not able to come this morning also asked me to give his regrets. They have
|
| 18 | both given me carte blanche to go ahead and speak to the written material
|
| 19 | which we have made available to the Committee last week. What I propose,
|
| 20 | therefore, to do is to simply touch on some of the highlights in that material
|
| 21 | without speaking to all of it in detail. But I will be happy to take questions on
|
| 22 | any of the more detailed points.
|
| 23 | What I would like to do is to highlight five areas. First what we |
17
| 1 | think are the four key points that we would want people to think about in broad
|
| 2 | brush in this area: to spend a little bit of time on what we see as the
|
| 3 | stakeholder incentives in this particular area; to discuss some things that we
|
| 4 | feel are sensible and appropriate general principles: to spend a moment on
|
| 5 | what we think is the most difficult issue, which is the question of notification
|
| 6 | and prior authorization before confidential information is shared; and finally,
|
| 7 | to speak briefly about waivers of confidentiality, which is the area that we feel
|
| 8 | is most promising for very significant progress in the short term.
|
| 9 | We have made an assumption not stated in our written material
|
| 10 | that the protection of confidential information of companies is an important
|
| 11 | thing. The assumption here is that there are not only compelling private
|
| 12 | interests that make this important but that there is a compelling public interest
|
| 13 | in protecting that confidentiality. I won't say a lot about that fact. On
|
| 14 | occasion I have encountered people who may express some doubt about that.
|
| 15 | If that assumption is one that the Committee does not share, I would be happy
|
| 16 | to speak to it in more detail. But we took that as our point of departure.
|
| 17 | From that we began to think about where we are currently, in
|
| 18 | terms of the practice in the sharing of confidential information as the three of
|
| 19 | us have seen it and experienced it. That experience is based in all of our cases
|
| 20 | as being lawyers in private practice who advise companies in merger and
|
| 21 | criminal and other cases which, as was said in the introduction, are clearly
|
| 22 | becoming increasingly international.
|
| 23 | The first point that I would like to emphasize is a relatively |
18
| 1 | unhopeful one, and that is that we do not think that there is going to be rapid
|
| 2 | progress on non-voluntary exchanges of confidential information unless
|
| 3 | agencies and their governments are prepared to introduce legal frameworks
|
| 4 | with relatively stringent and serious safeguards for the protection of that
|
| 5 | information. The basic reason for that conclusion is that private parties in the
|
| 6 | business community in most countries are going to be unlikely to perceive
|
| 7 | significant benefits in the non-voluntary settings and will have very significant
|
| 8 | concerns about the protection of privacy and fairness.
|
| 9 | Our second conclusion is much more optimistic, and that is that
|
| 10 | we believe that there is great scope for continued expansion of the use of
|
| 11 | voluntary waivers in merger cases and in some non-merger cases, particularly
|
| 12 | in the process of parallel settlement negotiations with multiple agencies. We
|
| 13 | are hopeful here because in those particular situations we see potential for
|
| 14 | significant benefits to both the enforcement agencies and to the private parties
|
| 15 | who are involved in the process.
|
| 16 | Our third conclusion, or perhaps recommendation would be a
|
| 17 | better characterization, is that in trying to make waivers more useful and
|
| 18 | acceptable, we think it is particularly important that waivers be truly voluntary
|
| 19 | and that they do not become an automatic activity. The issue around
|
| 20 | voluntariness is that, in the context of a merger and many other situations, the
|
| 21 | enforcement agencies have very significant practical leverage which results
|
| 22 | from the discretion that individual officials have in the activities that they
|
| 23 | undertake on a day-to-day basis in the investigation. We think that this is a |
19
| 1 | subject not much talked about that deserves some serious attention if we are to
|
| 2 | recommend a real enhancement in the use of voluntary waivers. With respect
|
| 3 | to waivers not becoming automatic, the concern is that waivers actually be
|
| 4 | requested and used in situations where there is, in fact, some real benefit to
|
| 5 | agencies and to the parties giving the waivers. There is a risk that, if waivers
|
| 6 | become habitual, they may be used in situations where they, in fact, expand the
|
| 7 | time and cost of an investigation process rather than reduce it.
|
| 8 | Finally, we note that there is very substantial variability right
|
| 9 | now in the legal and in the practical levels of confidentiality protection in
|
| 10 | jurisdictions around the world. Without naming names, we would have very
|
| 11 | serious concerns about exchanges of confidential information going into
|
| 12 | certain jurisdictions. There are other jurisdictions where the legal and
|
| 13 | practical degree of protection would be much higher and the level of trust and
|
| 14 | confidence would accordingly be much higher.
|
| 15 | And so what we would suggest for the United States as it thinks
|
| 16 | about going forward in this area would be to look ideally at a system that will
|
| 17 | be multilateral rather than a series of checkerboard bilaterals, but that would
|
| 18 | begin with jurisdictions in which there is a long history of cooperation to work
|
| 19 | from, where there is a high volume of cases to make the effort worthwhile, and
|
| 20 | where the other country and agency has a clear and well-established domestic
|
| 21 | track record on confidentiality. Over time, we would expect that more and
|
| 22 | more of the jurisdictions would come into a position of meeting those kind of
|
| 23 | criteria and could be added. |
20
| 1 | Let me now turn for a moment to the stakeholder incentives. It
|
| 2 | was our analysis of the two primary stakeholders which has led to a number of
|
| 3 | the conclusions that I have spoken about. From the perspective of enforcement
|
| 4 | agencies, we see significant benefits and no particular downsides to very broad
|
| 5 | scope for sharing of confidential information to facilitate enforcement in all
|
| 6 | cases -- merger cases as well as non-merger cases.
|
| 7 | From the perspective of private parties, the position is quite
|
| 8 | different. There are cases, particularly mergers, where possible time and cost
|
| 9 | savings can be very, very significant. And this ties into broader issues that the
|
| 10 | Committee is looking at about how to make cross-border merger review more
|
| 11 | efficient.
|
| 12 | I should actually digress to make a side comment that I meant to
|
| 13 | make in the introduction: we have had the benefit of reading a number of staff
|
| 14 | papers on a number of subjects, and while we were not speaking to those in
|
| 15 | detail, the three of us did want to say how much we were impressed by the
|
| 16 | scope and quality of analytical work that the Committee staff have been
|
| 17 | undertaking. There do seem to be some very, very useful and promising ideas
|
| 18 | being considered.
|
| 19 | Coming back to the comment on private parties, there is scope
|
| 20 | for advantages, particularly in merger cases, and in other settlement
|
| 21 | negotiations. But there are also, as you will have heard and will hear from the
|
| 22 | ICC, a number of very significant -- at least perceived and sometimes real --
|
| 23 | concerns, and a number of those are listed in our written material. I will just |
21
| 1 | touch on a couple of them here.
|
| 2 | One is simply the risk that increases every time you have
|
| 3 | information in multiple locations. It's the commercial business risk of
|
| 4 | disclosure of highly confidential information, and it is a particular feature of
|
| 5 | antitrust that you are working with marketing and strategic planning
|
| 6 | documents of the highest business sensitivity to organizations in many, many
|
| 7 | of the investigations.
|
| 8 | The second area is the incremental legal risk that companies face
|
| 9 | when confidential information which is potential evidence is disclosed to other
|
| 10 | jurisdictions. This is particularly significant where there are substantial
|
| 11 | differences between the legal systems in question. There are many similarities
|
| 12 | currently but also many significant substantive differences, as we all know,
|
| 13 | between the European and the American system or the Canadian and the
|
| 14 | American system, and even more when you consider some other jurisdictions.
|
| 15 | I think the Committee should consider that, to people outside the
|
| 16 | United States, the United States system is seen as a system that carries
|
| 17 | enormous legal risk in terms of the potential penalties, including criminal
|
| 18 | penalties, as well as the potential for private actions and treble damages and
|
| 19 | simply the time and cost of legal proceedings. That will be a factor as people
|
| 20 | outside the United States think about confidential information flowing into the
|
| 21 | United States.
|
| 22 | So we would say that private parties are seldom going to be
|
| 23 | motivated to expedite or enhance sharing information in what might be called |
22
| 1 | "violation" cases -- be they criminal conspiracy cases or other non-merger
|
| 2 | cases -- unless they are working towards a parallel settlement negotiation.
|
| 3 | Thus, we conclude that in non-merger cases, legislation and international
|
| 4 | agreements that have really substantial safeguards that will give private parties
|
| 5 | a comfort level about the protection of confidential information would be
|
| 6 | needed to facilitate information sharing. If the agencies and governments are
|
| 7 | not prepared to address those issues, we think there will be significant
|
| 8 | resistance to making progress on non-voluntary exchanges. On the other hand,
|
| 9 | we conclude that the use of waivers in merger cases is one where there is very
|
| 10 | significant scope to make progress in the short term. Indeed there is a lot
|
| 11 | already happening there.
|
| 12 | I would like to turn briefly to some of the general principles that
|
| 13 | we felt should be considered in this area. They are set out in some detail in the
|
| 14 | written material, so I'm just going to touch on them. One is with respect to the
|
| 15 | use of the confidential information and the basic ideas that it is used only for
|
| 16 | the designated purpose of advancing a particular investigation.
|
| 17 | We also make a number of more detailed suggestions that were
|
| 18 | actually inspired from commercial confidentiality agreements, which are very
|
| 19 | commonplace in all sorts of transaction settings. We think they have some
|
| 20 | useful concepts in terms of the disclosing party having discretion but not
|
| 21 | obligation to disclose information, requirements to return information, and the
|
| 22 | idea that there need to be remedies or sanctions if the agencies do not, in fact,
|
| 23 | adhere to the legal requirements that surround the protection of confidential |
23
| 1 | information. I think this is something that was touched on in what I regard as
|
| 2 | the seminal discussion of this whole area, which is the 1991 report of the
|
| 3 | ABA's International Antitrust Committee. We also comment briefly on how
|
| 4 | information should be treated. I'll touch only on one point there, which is the
|
| 5 | concept of national treatment -- that foreigners should not be discriminated
|
| 6 | against relative to domestic companies.
|
| 7 | The third principle is no downstream disclosure, and in our view
|
| 8 | this is the most fundamental item. It is again not one we thought of originally
|
| 9 | but one that was identified by the ABA's 1991 report. At a minimum it means
|
| 10 | a track record of no leaks and no free flow to other federal or to subfederal
|
| 11 | government agencies. But it also, to get a complete closed loop in the
|
| 12 | downstream, means closing off the ability of third parties to drag information
|
| 13 | out of the receiving agency using access to information laws or using discovery
|
| 14 | rules. We're not persuaded that there is any system in the world currently that
|
| 15 | has a complete closed loop with no downstream disclosure. Any shortfall from
|
| 16 | that raises an issue that is of concern to private parties in a particular case,
|
| 17 | whether it is a voluntary or non-voluntary exchange.
|
| 18 | The fourth point is the preservation of legal privileges. This is a
|
| 19 | detailed and difficult area. The basic points we would like people to think
|
| 20 | about here are that there may be privileges that belong to the agencies but also
|
| 21 | privileges that belong to the private parties involved in having provided
|
| 22 | information. We think that what makes sense is a "highest common
|
| 23 | denominator," where the privilege can be claimed at the highest level available |
24
| 1 | in either the receiving or the disclosing jurisdiction.
|
| 2 | The fifth point is that the receiving agency should be under an
|
| 3 | obligation to assert whatever confidentiality and privilege claims can be made.
|
| 4 | We think at that stage there is also a need, when the third party is seeking
|
| 5 | information by discovery or access to information laws, to have a notification
|
| 6 | mechanism so that the private parties affected also have the opportunity to use
|
| 7 | their best efforts to protect their information, which may include disclosure
|
| 8 | subject to an appropriate protective order.
|
| 9 | Finally, we strongly encourage the use of policy statements in all
|
| 10 | of the jurisdictions that would be involved in this type of process. They would
|
| 11 | play an important role in fostering the overall transparency of activity of
|
| 12 | agencies in this area. Such statements could usefully set out in plain language
|
| 13 | what the confidentiality laws and policies are in a short and clear way, as well
|
| 14 | as the treatment of privilege and other issues of discretion that an agency may
|
| 15 | have in dealing with exchanged information.
|
| 16 | I would like to comment briefly on notification and prior
|
| 17 | authorization, which we expect will be the most controversial and critical issue
|
| 18 | in any attempt to introduce non-voluntary legislated information exchanges. In
|
| 19 | light of the time, I won't speak to this in a lot of detail. But in the questions I
|
| 20 | can elaborate with some examples, in particular from Canada. I think
|
| 21 | basically the agency concern here is that notification and/or prior
|
| 22 | authorization, whether by a judge or some other official, before an exchange of
|
| 23 | confidential information occurs will either be burdensome to the conduct of |
25
| 1 | investigations or there will be the loss of the surprise element, which may be
|
| 2 | important for the effectiveness of the investigation.
|
| 3 | We have not heard either of those arguments really articulated in
|
| 4 | a way that is terribly persuasive -- or any other terribly persuasive arguments
|
| 5 | about why there can never be notification or prior authorization. There is a
|
| 6 | delicate balancing issue in cases where there is a real threat of destruction of
|
| 7 | evidence or some other prejudice to investigations, but those, I think, are
|
| 8 | relatively rare cases objectively considered.
|
| 9 | I would like to end, then, with our thoughts on the area where we
|
| 10 | would hope to see short-term progress. That is in the use of voluntary waivers
|
| 11 | of confidentiality which, as the Committee knows, are now a significant feature
|
| 12 | of modern merger practice and have been used in a few non-merger cases that
|
| 13 | are well known.
|
| 14 | As I said at the outset, the question of what is voluntary is, in
|
| 15 | our view, a very critical issue. What we would like to see is that when
|
| 16 | agencies are requesting waivers, they identify potential benefits, such as
|
| 17 | opportunities to save time and cost in an investigation. It would be
|
| 18 | constructive to identify the areas where parties under investigation or parties
|
| 19 | to a merger may find it in everyone's interest to have a waiver. The waiver
|
| 20 | may relate to documents or discussions and it may be a blanket waiver or a
|
| 21 | restricted limited waiver.
|
| 22 | What we are concerned about is that agencies not use pressure or
|
| 23 | threats or implied threats of, for example, slowing down the review of a |
26
| 1 | merger, broadening the scope of an investigation, or other things that can be
|
| 2 | done and are difficult to control at the practical day-to-day level. We don't
|
| 3 | have full answer to this area of unease, although we do think that one helpful
|
| 4 | step would be in the policy statements that we referred to earlier: for an agency
|
| 5 | to say as a matter of policy that it will not use threats of prejudice in the law
|
| 6 | enforcement investigation by delay or whatever would be helpful as a matter of
|
| 7 | policy.
|
| 8 | In terms of more concrete ways to move forward I think what we
|
| 9 | see right now in waivers is relatively simplistic and somewhat lacking in
|
| 10 | standardization, and that there would be room to develop model waivers that
|
| 11 | are perhaps more balanced than the current waiver -- which basically tends to
|
| 12 | say "we waive all our rights" -- not particularly balanced from the perspective
|
| 13 | of the private party. In light of some of the things we have touched on earlier
|
| 14 | about the way in which confidential information may be used and treated, the
|
| 15 | treatment of privilege, and the assertion of confidentiality and privilege claims,
|
| 16 | if agencies were prepared to look at a model waiver in which there were some
|
| 17 | commitments from the agencies with respect to the way in which they would
|
| 18 | use and treat the information and approach the protection of it, that that would
|
| 19 | very significantly enhance the attractiveness of waivers to private parties who
|
| 20 | are asked to think about giving them.
|
| 21 | That I think is where I should stop in terms of the summary of
|
| 22 | the views we have come to. I would be happy to take any questions. Thank
|
| 23 | you. |
27
| 1 | MR. RILL: Neil, thanks very much. I'm sure that all of us have
|
| 2 | a number of questions which we'll defer until all the panelists have an
|
| 3 | opportunity to speak. Next, Klaus Becher.
|
| 4 | MR. BECHER: First I would like to thank the Committee for
|
| 5 | inviting the International Chamber of Commerce to present its views in this
|
| 6 | hearing. ICC has formed a working group which I have the honor to chair. We
|
| 7 | have been operating in a very tight time frame and we had the first meeting in
|
| 8 | the beginning of March. So I have to add a caveat which Neil also has added
|
| 9 | with his remarks. We have not a formally-adopted ICC position, but at least
|
| 10 | we have been able to come up with a draft paper which will be distributed
|
| 11 | afterwards.
|
| 12 | I'm working for DaimlerChrysler and I can state actually, from
|
| 13 | my own experience, that the increasingly international nature of business
|
| 14 | transactions has not only resulted in a growing number of mergers and
|
| 15 | cooperation projects but also in a growing number of jurisdictions you have to
|
| 16 | deal with when you want to get such a merger or another transaction approved.
|
| 17 | In response to this, it's understandable that competition
|
| 18 | authorities are examining means of cooperation to facilitate and coordinate
|
| 19 | their respective review and their investigation and decision-making processes.
|
| 20 | The business community certainly recognizes the potential
|
| 21 | benefits of such cooperation, but the business community has also been greatly
|
| 22 | concerned by one of its main elements, which is the exchange of confidential
|
| 23 | corporate information. |
28
| 1 | Confidential information supplied by companies to competition
|
| 2 | authorities in the context of merger reviews or antitrust investigations often
|
| 3 | includes extremely sensitive information relating to the strategy of the
|
| 4 | company, its investment plans, and its marketing roles and methods. To give
|
| 5 | you an example, in the merger proceedings relating to the merger between
|
| 6 | DaimlerChrysler, we had to provide our marketing plan for the next five years
|
| 7 | relating to passenger cars both to the authority in Brussels and to the Federal
|
| 8 | Trade Commission in Washington. And the parties are certainly highly
|
| 9 | interested that these marketing plans not become known to their competitors.
|
| 10 | Indeed, if such information falls into the hands of competitors of
|
| 11 | the company involved or into the public domain, which is even worse, this
|
| 12 | could have serious adverse consequences on the competitive position of the
|
| 13 | company or its share market value. This risk is not theoretical, especially
|
| 14 | when information is sent to countries where the company providing the
|
| 15 | information faces strong competition, especially from state-owned companies
|
| 16 | or in the context of mergers when share prices are especially volatile. ICC,
|
| 17 | therefore, applauds the initiative of the International Competition Policy
|
| 18 | Advisory Committee in addressing this issue and in inviting the international
|
| 19 | business community to contribute to its work in this area.
|
| 20 | We have been working for several years on issues arising out of
|
| 21 | the increasing cooperation between antitrust authorities which have an impact
|
| 22 | on business. ICC has issued a paper in 1996, which is called the ICC 1996
|
| 23 | Statement, setting out business concerns relating to the exchange of |
29
| 1 | confidential information between antitrust authorities and also suggested
|
| 2 | safeguards to reduce the risks of prejudice to the companies concerned. ICC
|
| 3 | has now been asked by ICPAC to submit views on its core concerns arising
|
| 4 | from the exchange of confidential information and recommendations to address
|
| 5 | these concerns.
|
| 6 | As to the scope of our draft paper, we will focus on information
|
| 7 | exchanged in the merger review context, and I will explain later why.
|
| 8 | Cooperation between authorities in the merger area is increasing substantially,
|
| 9 | as multijurisdictional merger transactions become more common. To ensure
|
| 10 | transparency and predictability for both companies and authorities involved in
|
| 11 | multijurisdictional merger notifications, ICC feels that it is essential to have
|
| 12 | internationally agreed standards accepted by authorities as well as by
|
| 13 | companies, which would be integrated into multilateral as well as bilateral
|
| 14 | agreements.
|
| 15 | With respect to the non-merger area, we make reference to the
|
| 16 | ICC 1996 Statement, which will be attached to our draft paper on exchange of
|
| 17 | confidential information. The 1996 paper pointed out that although certain
|
| 18 | overarching competition law principles are generally accepted in major trading
|
| 19 | countries, considerable differences in the international antitrust laws still do
|
| 20 | exist.
|
| 21 | Some members, especially in North America, did not feel that
|
| 22 | further convergence of these laws needs to be a precondition for information
|
| 23 | exchange. Other ICC members, particularly in Europe, felt that with the |
30
| 1 | current low level of convergence, cooperation between antitrust authorities
|
| 2 | should not include the exchange of confidential information. Being a European
|
| 3 | lawyer, I would like to point out some of the differences which actually have
|
| 4 | caused the European ICC members to feel different from their North American
|
| 5 | colleagues.
|
| 6 | These differences are also set out in the 1996 paper. Most
|
| 7 | important is that the EU competition system is an administrative
|
| 8 | prohibition-based system, which actually encourages companies to file a large
|
| 9 | quantity of business information to obtain exemptions and immunity. The U.S.
|
| 10 | system is an essentially litigious system driven by private parties, where less
|
| 11 | business information is regularly supplied by companies.
|
| 12 | While in the U.S., which extends its antitrust jurisdiction to acts
|
| 13 | having an effect of its export commerce, antitrust offenses can lead to criminal
|
| 14 | penalties and treble damages, antitrust offenses are purely a civil matter in the
|
| 15 | EU, and the European Commission's jurisdiction is limited to acts implemented
|
| 16 | and effecting competition within the EU.
|
| 17 | Another area of difference which is of particular concern to
|
| 18 | business is the extent to which competition authorities are able to resist
|
| 19 | disclosure to third parties. In some jurisdictions the competition authority
|
| 20 | could be obliged to disclose information for the purpose of legal proceedings
|
| 21 | involving third parties. Despite these differences, ICC members were,
|
| 22 | however, unanimous in their concern that any confidential corporate
|
| 23 | information exchanged should be properly protected. The 1996 paper stressed |
31
| 1 | that companies should be given prior notification before any proposed
|
| 2 | information exchange, and recommended several other safeguards.
|
| 3 | The ICC 1996 Statement also pointed out that alternative forms
|
| 4 | of cooperation to information sharing agreements, such as ad hoc cooperation
|
| 5 | with the company's consent, could help avoid some of the problems discussed.
|
| 6 | Now to the exchange of information in the merger context. Of
|
| 7 | course, companies have an interest in reducing the administrative burden,
|
| 8 | costs, and delays resulting from multijurisdictional merger reviews. I said this
|
| 9 | morning to Janet McDavid in the DaimlerChrysler merger we had to file in nine
|
| 10 | different jurisdictions, and I felt ashamed because Janet told me that she is
|
| 11 | working on a case where 27 different jurisdictions are involved. And I am
|
| 12 | afraid that this number may even increase in the future when countries learn
|
| 13 | more about competition laws and enact their own national laws.
|
| 14 | Companies have an interest in ensuring that the decisions given
|
| 15 | by different authorities are consistent, which is not difficult in a case which
|
| 16 | does not involve any substantial antitrust issues, like the DaimlerChrysler
|
| 17 | merger, but which may be difficult in cases which involve 27 jurisdictions with
|
| 18 | 27 different views.
|
| 19 | To the extent that the exchange of certain information could help
|
| 20 | ease the problems associated with multijurisdictional merger review,
|
| 21 | companies are often prepared to consent to authorities exchanging their
|
| 22 | confidential information and to accept the risks associated with this in the hope
|
| 23 | of a speedier, more consistent, and less costly and burdensome merger review |
32
| 1 | process.
|
| 2 | To foster this mutually beneficial cooperation between
|
| 3 | companies and competition authorities, however, it is essential that a high
|
| 4 | degree of trust in the will and the ability of competition authorities to ensure
|
| 5 | the protection of such information is extended.
|
| 6 | We have to keep in mind that information exchange is only one,
|
| 7 | but a very important, element in the broader framework, and other approaches
|
| 8 | to ease problems arising from multijurisdictional merger review must also be
|
| 9 | pursued. These include reduction of the information required to the essential
|
| 10 | minimum -- right now I think the antitrust authorities go exactly in a different
|
| 11 | direction -- harmonization and transparency of substantive and procedural
|
| 12 | requirements to the extent possible; clear time frames; and more frequent use
|
| 13 | of what we call negative comity, that is, when authorities decline to exercise
|
| 14 | their jurisdiction.
|
| 15 | This principle may assume changes to national legislation, but
|
| 16 | from a business community point of view we should discuss not only positive
|
| 17 | comity but also negative comity. I'm only afraid that no country has the
|
| 18 | courage to enact laws which provide for negative comity. This can probably
|
| 19 | only be done on an international treaty basis, if at all.
|
| 20 | We have then discussed principles for the exchange of
|
| 21 | confidential information in multijurisdictional merger cases, and the ICC
|
| 22 | Working Party, at this stage, recommends that the following set of principles
|
| 23 | should be applied when confidential information is exchanged in |
33
| 1 | multijurisdictional merger cases. And these principles should be integrated
|
| 2 | into multilateral and bilateral agreements.
|
| 3 | As to the preconditions for exchange: confidential information
|
| 4 | should only be exchanged with the consent of the parties involved from whom
|
| 5 | the information was obtained. Where such information is the property of a
|
| 6 | third party, authorization should also be obtained from that party.
|
| 7 | The terms and conditions under which the company consents to
|
| 8 | the exchange should be set out and agreed by the company and the competition
|
| 9 | authority supplying the information.
|
| 10 | The second precondition: information exchange procedures
|
| 11 | should be fair and transparent and carried out in consultation with the
|
| 12 | companies owning the information. For example, companies must be given the
|
| 13 | opportunity to explain any information transmitted which could be
|
| 14 | misinterpreted.
|
| 15 | A further precondition: the competition authority requesting the
|
| 16 | information should have exhausted its own administrative possibilities for
|
| 17 | obtaining the information independently before making the request. The next
|
| 18 | precondition: any exchange of information should speed up the investigative
|
| 19 | process rather than lead to extra delays.
|
| 20 | Next precondition: information exchanged should be subject to
|
| 21 | conditions of confidentiality in the receiving jurisdiction, at least as stringent
|
| 22 | as those of the jurisdiction supplying the information. Legal safeguards in the
|
| 23 | receiving jurisdiction should ensure that information exchanged will not be |
34
| 1 | disclosed to third parties.
|
| 2 | Last condition: the principle of reciprocity should be respected.
|
| 3 | That is, the competition authorities supplying and receiving the information
|
| 4 | should both agree to follow the same rules regarding the exchange of
|
| 5 | information.
|
| 6 | The next subject we discussed was the scope and duration of
|
| 7 | information exchange. Information should be considered to be confidential
|
| 8 | when firstly the owner/provider company itself defines the information as being
|
| 9 | confidential; or secondly, the information is considered to be confidential or
|
| 10 | subject to legal professional privilege by domestic legislation of the supplying
|
| 11 | or the receiving authority. We do not claim that information has to be treated
|
| 12 | as confidential when it's publicly available, of course.
|
| 13 | The information for which consent is required for exchange
|
| 14 | should be precisely identified and consent must be sought for any modifications
|
| 15 | to the scope of the information exchange.
|
| 16 | We believe that the identification of confidential information for
|
| 17 | exchange should be done on a case-by-case basis and suggest that it would be
|
| 18 | difficult to identify categories of confidential documents that agencies could
|
| 19 | share under a waiver as suggested in the ICPAC staff draft protocol on
|
| 20 | international agency cooperation.
|
| 21 | Of course, should information exchange be limited to the
|
| 22 | necessary minimum, the transmission of information must be limited in time
|
| 23 | and be returned to the owner or respective provider company after the agreed |
35
| 1 | time period elapses. All notes and copies of the information must be destroyed
|
| 2 | to prevent institutional knowledge.
|
| 3 | To the circumstances of disclosure: the company should be
|
| 4 | informed of the identity of the authority or the authorities to whom the
|
| 5 | information would be sent, the terms and conditions under which the supplying
|
| 6 | authority was providing information to the other authority; the national rules
|
| 7 | governing the use of the confidential information which would bind the
|
| 8 | receiving authority, and last, but not least, the date of the proposed disclosure.
|
| 9 | We also feel that we need to establish conditions for the use by
|
| 10 | the receiving authority of the information exchanged. The use should be
|
| 11 | limited to the purpose and to proceedings for which the company providing the
|
| 12 | information agreed to its transfer. Secondly, information exchanged should not
|
| 13 | be disclosed to any parties outside the receiving authority, in particular
|
| 14 | third-party plaintiffs, other agencies or governments. Legal safeguards should
|
| 15 | be put into place to ensure that such information will not be disclosed to third
|
| 16 | parties.
|
| 17 | ICC has serious concerns about information being supplied to
|
| 18 | any jurisdiction without these safeguards. Where such an unsatisfactory
|
| 19 | situation exists, authorities in the receiving jurisdiction must commit to
|
| 20 | resisting attempts by third parties to obtain information from them, including
|
| 21 | by invoking all available privileges and exercising any prerogatives under
|
| 22 | Freedom of Information legislation.
|
| 23 | Next condition: the information exchanged should be subject to |
36
| 1 | legal professional privilege when it would be considered as deemed so under
|
| 2 | the rules of either the supplying or receiving jurisdiction.
|
| 3 | We then focus on a scenario where the agreed terms of exchange
|
| 4 | are not respected. If terms and conditions under which a company agreed to
|
| 5 | information exchange are not respected, it should have the right to obtain the
|
| 6 | immediate return of the information from the receiving authority and not be
|
| 7 | obliged to provide further information.
|
| 8 | We also feel that it would be desirable for the company to have
|
| 9 | the possibility of seeking judicial relief, including orders for the return of all
|
| 10 | or part of documents or information provided, and constraining the use by the
|
| 11 | foreign authority of all or part of the documents or information. However, we
|
| 12 | are aware that mechanisms to make this possible in an international context are
|
| 13 | still not in place.
|
| 14 | As to the confidentiality waiver agreement between a company
|
| 15 | and a competition authority, Neil has already touched on issues which we also
|
| 16 | discussed. We suggest that the following elements should be included in any
|
| 17 | agreement in which a company party to a merger consents to a competition
|
| 18 | authority providing its confidential information to another competition
|
| 19 | authority.
|
| 20 | First, the identity of the authority to whom the information will
|
| 21 | be sent. Second, the date of the proposed disclosure. Third, the date on which
|
| 22 | the information will be returned together with an understanding that all notes
|
| 23 | and copies of the information with the receiving authority will be destroyed. |
37
| 1 | Fourth, the purpose for which the information is being exchanged. Next,
|
| 2 | precise identification of the information to be exchanged, together with an
|
| 3 | understanding that further consent will be sought if the scope of the
|
| 4 | information to be exchanged is modified.
|
| 5 | Next point: a description of the national rules governing use of
|
| 6 | the confidential information by the receiving authority. Then the terms and
|
| 7 | conditions under which the supplying authority is providing information to the
|
| 8 | receiving authority, which should include undertakings by the receiving
|
| 9 | authority that the use of the information will be limited to the purpose and to
|
| 10 | proceedings for which the company providing the information agrees to its
|
| 11 | transfer; and that the information exchanged will not be disclosed to any
|
| 12 | parties outside the receiving authority, in particular third-party plaintiffs,
|
| 13 | other agencies or governments. And it will resist attempts by third parties to
|
| 14 | obtain information from it, including by invoking all available privileges and
|
| 15 | exercising any prerogatives under Freedom of Information legislation.
|
| 16 | Last: a provision that in the event that the terms and conditions
|
| 17 | under which a company agreed to information exchange are not respected, the
|
| 18 | company should have the right to obtain the immediate return of the
|
| 19 | information. The company should not be obliged to provide further
|
| 20 | information, and the authority should make no further use of the information in
|
| 21 | question. It would also be desirable for the company to be assured of the
|
| 22 | possibility of obtaining judicial relief as discussed, but ICC has also stated
|
| 23 | that the required mechanisms are still not in place. |
38
| 1 | Again, thank you for the opportunity to be involved in the
|
| 2 | discussion of a highly fascinating subject. ICC is certainly prepared to
|
| 3 | continue discussions in this field, which hopefully will lead to a solution which
|
| 4 | is satisfactory to both the antitrust authorities and the business community.
|
| 5 | Thank you.
|
| 6 | MR. RILL: Thank you, Klaus. I'm sure we'll have questions,
|
| 7 | not only today but down the road as we formulate our own recommendations
|
| 8 | that we'll be addressing to the ICC. Thank you for the very thoughtful input.
|
| 9 | Jan, Phil, how do you want to proceed?
|
| 10 | DR. STERN: Excuse me, before you do, I am wondering if you
|
| 11 | have any paper that accompanies your statement. Okay. Thank you.
|
| 12 | I've been spoiled by my experience at the International Trade
|
| 13 | Commission. I always like to have prehearing briefs or something so that I can
|
| 14 | prepare questions, so I'll have to listen to you more carefully.
|
| 15 | MR. PROGER: The Section of Antitrust Law is preparing
|
| 16 | papers. We hope at the May 17th hearing, when the two ABA panels appear,
|
| 17 | that we will have permission to present those papers. Jim, as a past Chair of
|
| 18 | the Section knows, we have to go through ABA procedures to present the
|
| 19 | papers, but we are working on that process.
|
| 20 | MR. RILL: And it makes the federal government look like a
|
| 21 | smoothly running operation.
|
| 22 | MS. McDAVID: It does.
|
| 23 | MR. RILL: Let me acknowledge the presence of another one of |
39
| 1 | our Committee members, Tom Donilon, who joined us here a little while ago.
|
| 2 | Tom is with O'Melveny & Myers and is a former high-ranking State
|
| 3 | Department official.
|
| 4 | DR. STERN: If I might just say, if my request has any
|
| 5 | assistance or any weight at all, I would appreciate having something in writing
|
| 6 | on the 17th. Thank you.
|
| 7 | MR. RILL: Phil?
|
| 8 | MR. PROGER: Jim and Paula, thank you for having me again.
|
| 9 | It is a privilege to be here. I do want to acknowledge that working with Merit,
|
| 10 | Cynthia, Andrew and Stephanie has been a real delight. And Merit, I greatly
|
| 11 | appreciate the assistance and cordiality that you have provided. I might say on
|
| 12 | a personal note, it is kind of a privilege to be here today testifying before
|
| 13 | Eleanor Fox. Eleanor started me in the Section. I worked for her, I will not
|
| 14 | say how long ago, Eleanor, but it was on the original Hart-Scott-Rodino
|
| 15 | legislation.
|
| 16 | At the outset, I am obligated to issue a disclaimer on behalf of
|
| 17 | Jan and myself. We appear here today as individuals and not as Chair-Elect or
|
| 18 | Chair of the American Bar Association's Section of Antitrust Law. Our views
|
| 19 | are our own and not the views of either the American Bar Association or its
|
| 20 | Section of Antitrust Law.
|
| 21 | I guess we all wear a lot of hats here. I must say that Neil and
|
| 22 | Klaus were kind enough to provide their papers to us in advance. I do not
|
| 23 | know if they are aware, but I am a member of both their organizations, and I |
40
| 1 | was proud to be a member when I read their excellent papers. They are both,
|
| 2 | to quote Neil's partner, Bill Rowley, first rate. And I will not try and repeat
|
| 3 | the various considerations, recommendations, and ideas expressed in them
|
| 4 | other than to say, I do sincerely believe they are very well thought out and
|
| 5 | cover the issues excellently.
|
| 6 | So with that said, let me see if I can provide a little bit of a
|
| 7 | different slant. When I testified last, I indicated that I was skeptical that there
|
| 8 | is a significant issue of confidentiality in multijurisdictional transactions and
|
| 9 | investigations. Given the differences worldwide in our substantive laws and
|
| 10 | processes trying to create a system in which there is non-voluntary mandated
|
| 11 | disclosure will create a lot of problems, many of which I think are difficult
|
| 12 | even to foresee today.
|
| 13 | Neil made the comment that many non-Americans look at the
|
| 14 | U.S. adversarial system with concern and horror. I can assure you, Neil, that
|
| 15 | many Americans feel the same way at times about our system. We have a
|
| 16 | different system of enforcement, and in that system those being investigated by
|
| 17 | the respective agencies must be aware of two things that are somewhat unique
|
| 18 | to the United States, although maybe one of them has a parallel in the
|
| 19 | European Union.
|
| 20 | One is we do have a system of private litigation, and while one
|
| 21 | can argue that compulsory mandated disclosure to enforcement agencies would
|
| 22 | not be turned over to private litigants, in point of fact private litigants are a
|
| 23 | little bit smarter than that. What they will do is go to the court and they say to |
41
| 1 | the court that the parties have already produced this information to the various
|
| 2 | enforcement agencies. Just compel the parties to give us what they have given
|
| 3 | already the various enforcement agencies.
|
| 4 | Moreover, the information that you have been compelled to give
|
| 5 | may be beyond the scope of what a private litigant in the United States may
|
| 6 | otherwise be entitled to discover. So I think the underlying linchpin of our
|
| 7 | litigation system poses some considerations that ICPAC should carefully
|
| 8 | consider before recommending compulsory disclosure.
|
| 9 | Secondly, and to some extent there is a parallel with the
|
| 10 | European Commission and the Member States, we have in the United States
|
| 11 | multiple sovereigns. Not only can the federal government, either the Federal
|
| 12 | Trade Commission or the Department of Justice, conduct investigations, but
|
| 13 | also can one or more states. Usually the federal agency and the states
|
| 14 | cooperate in their investigations, but not always. While the existence of
|
| 15 | private litigation and multiple sovereigns does not make mandated confidential
|
| 16 | disclosure impossible, it does complicate the process.
|
| 17 | In addition, there are at times different public policies than
|
| 18 | purely competition. And these other public policies, which often are non-
|
| 19 | competition policies, can raise significant problems when information has been
|
| 20 | turned over to competition enforcement authorities, but now are available for
|
| 21 | other uses. So disclosure, particularly in situations where it goes to
|
| 22 | organizations that have not established the history of somewhat apolitical
|
| 23 | dedication to competition principles, raises serious concerns. |
42
| 1 | And there are reasons why, in representing zealously a client,
|
| 2 | that may not be in the best interests of the client.
|
| 3 | One, it can affect, frankly, some of your tactics in defending
|
| 4 | your client. There may be reasons why at a particular point in time it would be
|
| 5 | premature with respect to one party to turn over information that is perfectly
|
| 6 | mature and appropriate with respect to another party. Two, it could broaden
|
| 7 | the scope of either a private litigant's case or another competition authority's
|
| 8 | case by providing information to them that really is outside the core scope of
|
| 9 | their investigation, but now raises issues that they feel that they must look into
|
| 10 | even if tangential. So it adds burden and expense.
|
| 11 | Nevertheless, If ICPAC feels that there should be a
|
| 12 | recommendation of some mandatory disclosure, I would suggest that some of
|
| 13 | the following considerations be considered.
|
| 14 | One, I think there should be greater transparency in how the
|
| 15 | enforcement process works and under what context information will be
|
| 16 | disclosed by and between competition authorities.
|
| 17 | Two, there should be improved awareness and transparency of
|
| 18 | confidentiality protections which apply in foreign jurisdictions. If we're going
|
| 19 | to go down this road, I think that the jurisdictions involved need to be open and
|
| 20 | transparent on their laws and make it clear when you provide confidential
|
| 21 | information what your protections are, what your rights are, and what the
|
| 22 | process is to protect your rights.
|
| 23 | Three, there have been a few statements by senior competition |
43
| 1 | authorities suggesting that failure to agree to waive confidentiality protections
|
| 2 | may create an adverse inference. I think that it must be very clear that such an
|
| 3 | inference is not appropriate and that there may be perfectly legitimate reasons
|
| 4 | why a party may not want to waive national confidentiality protections to allow
|
| 5 | enforcement agencies to exchange and share the party's confidential
|
| 6 | information. And I have tried to enumerate reasons, such as private litigation
|
| 7 | in the United States or the use of the information for non-competition reasons,
|
| 8 | why parties may be reluctant to waive confidentiality.
|
| 9 | Four, any exchange of confidential information on a mandatory
|
| 10 | basis must fully maintain and protect the attorney-client privilege. That, I
|
| 11 | think, is fundamental to our system of jurisprudence in the United States, and
|
| 12 | to due process.
|
| 13 | Five, if there are to be mandatory disclosures or waivers, they
|
| 14 | should be limited in scope, while reducing the volume, not increasing the
|
| 15 | volume that a party must in aggregate produce. I think there is a real danger
|
| 16 | that we might end up with the lowest common denominator and everyone seek
|
| 17 | their own Christmas ornament. And thus, in fact, the parties end up with
|
| 18 | increased burden.
|
| 19 | And if the documents are produced, then there must be a clear
|
| 20 | understanding of the limits on their use and that there use is for competition
|
| 21 | law enforcement purposes only. If there is going to be mandatory disclosure,
|
| 22 | there must be no right of the parties receiving the information to further
|
| 23 | disclose them to other parties without permission. |
44
| 1 | Finally, I think that there should be some ability of the parties
|
| 2 | involved to receive notice before any exchange or disclosure is made. Parties
|
| 3 | should have an absolute right to be able to obtain a review before a neutral
|
| 4 | decision maker, such as an Article III Judge in the United States, before their
|
| 5 | documents originally obtained through mandated disclosure are turned over to
|
| 6 | a third-party.
|
| 7 | Right now the enforcement processes in the United States and
|
| 8 | the European Commission, particularly with respect to merger enforcement,
|
| 9 | are different. The European Commission approach is much more front-ended,
|
| 10 | while the U.S. approach, with our second request and ultimate potential
|
| 11 | litigation, is more back-ended. Timing differences should be acknowledged,
|
| 12 | and the parties should have some right to have some say over the timing.
|
| 13 | Last, if we are going to go in the direction of mandated
|
| 14 | disclosure and sharing among enforcement agencies, we are probably better off
|
| 15 | with bilateral negotiation, initially with the European Commission, and using
|
| 16 | what develops from that negotiation as a model. But I would only do so if
|
| 17 | there is a limitation placed on DG-IV's requirement of transferring information
|
| 18 | to Member States. But if that could be dealt with and if we are going to go in
|
| 19 | this direction, despite what I view as some significant pitfalls, I think bilateral
|
| 20 | negotiations principally with DG-IV is probably the starting point.
|
| 21 | I thank ICPAC for the opportunity to appear here today. You
|
| 22 | have a difficult task and I hope that my comments are helpful. Thank you.
|
| 23 | MR. RILL: Thank you, Phil. Jan? |
45
| 1 | MS. McDAVID: I'm going to speak principally from my
|
| 2 | perspective of having been involved in a number of multinational mergers,
|
| 3 | including the one to which Klaus referred in which we are filing in 27
|
| 4 | jurisdictions, which is the "mother of all multinational mergers," as well as
|
| 5 | civil investigations, principally, as well as based on one or two criminal
|
| 6 | proceedings.
|
| 7 | In addition, I participated with Jim Rill, my colleague Tom
|
| 8 | Leary, and Bob Weinbaum in providing input to the Division and Federal
|
| 9 | Trade Commission on the IAEAA. We were particularly interested in the
|
| 10 | provision that excepted Hart-Scott-Rodino material from disclosure pursuant
|
| 11 | to what we call the "Vowel Act," because it is otherwise unpronounceable,
|
| 12 | based on concerns of disclosure of confidential information, particularly
|
| 13 | among the European Commission and its member jurisdictions. I think most of
|
| 14 | those fears have not materialized, but it was an absolutely legitimate concern
|
| 15 | at the time.
|
| 16 | I want to compliment both Neil and Klaus on their excellent
|
| 17 | papers. There really are some very important but subtle points in there that I
|
| 18 | hope the Advisory Committee will pay attention to as you proceed to your
|
| 19 | recommendations.
|
| 20 | The data gathered in a merger investigation, as Klaus has
|
| 21 | already explained, truly are the crown jewels of a corporation, current and
|
| 22 | forward-looking strategic planning data and marketing data, the disclosure of
|
| 23 | which could be incredibly damaging to the company on a competitive basis or |
46
| 1 | even in a political context. I've represented foreign companies in the United
|
| 2 | States, and I've represented American companies in foreign jurisdictions, and
|
| 3 | there is always a fear that if you are not a national of the regulating authority,
|
| 4 | you are going to be treated differently somehow than nationals may be treated.
|
| 5 | My foreign clients have been worried that they will be subject to
|
| 6 | greater regulation. My American clients in Europe are worried that a
|
| 7 | European firm may secure an advantage over them as a consequence of
|
| 8 | information they disclose or, perhaps, that a decision may be made in a matter,
|
| 9 | and may have motivations that are not entirely on the merits. And the
|
| 10 | confidentiality of the information is in many ways the linchpin of all of that,
|
| 11 | because this information is so sensitive.
|
| 12 | The parties' objectives in consenting, as they often do, to the
|
| 13 | sharing of information I think are important to consider. In my experience the
|
| 14 | issue of time and of cost savings is rarely actually realized. What really
|
| 15 | happens is that everybody gets more than they might otherwise get. The
|
| 16 | Federal Trade Commission or the Department of Justice will want everything
|
| 17 | that is disclosed, all the filings that are given to the foreign authorities, and the
|
| 18 | foreign authorities will want some of what is given to the United States
|
| 19 | agencies.
|
| 20 | What you really gain perhaps is the ability to coordinate the
|
| 21 | timing of the decisions at the various agencies so that you're not going to be
|
| 22 | gamed between decision points. And you are more likely to assure consistent
|
| 23 | analysis and consistent outcome and probably an outcome that is more likely to |
47
| 1 | be on the merits and less likely to be politically motivated. Assurances of
|
| 2 | confidentiality, as all the other speakers have said, is absolutely critical to
|
| 3 | this.
|
| 4 | The risk of inconsistent privileges in different jurisdictions can't
|
| 5 | be overemphasized. Here, for example, we have the problem that material that
|
| 6 | would be testimony before a grand jury taken under waivers or assurances of
|
| 7 | confidentiality or immunity arrangements may be transferred to the Canadian
|
| 8 | government under the MLAT and then come back into the United States for use
|
| 9 | in civil litigation.
|
| 10 | The European Union has different rules with respect to the
|
| 11 | attorney-client privilege than the United States does, and those differences are
|
| 12 | very significant. And so, for example, we are often concerned that
|
| 13 | communications by inside counsel are not recognized as privileged in Europe,
|
| 14 | although they are recognized as privileged in the United States. Those
|
| 15 | materials may, through the back door, become available to the American
|
| 16 | agencies when they would not otherwise have been, as a result of the exchange
|
| 17 | of information.
|
| 18 | All of the waivers that I have been involved in, and there have
|
| 19 | been many, are all "one off." And that is an important point I think, and I
|
| 20 | would emphasize as the others have, desirability of transparency and some
|
| 21 | protocols in this area to minimize the need to engage in a one-off negotiation
|
| 22 | with respect to every transaction.
|
| 23 | In this regard, as Phil did, I would like to point you to the |
48
| 1 | protocol that exists between the federal agencies and the state attorneys
|
| 2 | general. It is often the subject of additional negotiation, but the protocol at
|
| 3 | least provides a uniform starting point for all of those negotiations, and I think
|
| 4 | we all learned something from each of those negotiations. The states are even
|
| 5 | talking about modifying their protocol based on the many negotiations they
|
| 6 | have had with private parties and the things they have learned. A great deal
|
| 7 | more transparency about what sorts of provisions are commonplace and how
|
| 8 | you deal with issues like the protection of the attorney-client privilege in the
|
| 9 | context I described would be very useful to the parties and to the business
|
| 10 | community.
|
| 11 | Today my clients have been willing to agree to waivers of
|
| 12 | confidentiality principally with respect to the major jurisdictions, such as the
|
| 13 | European Commission, the Canadian government, the Australian government,
|
| 14 | and the New Zealand government, which have an established track record of
|
| 15 | confidentiality. I think there would be far greater reluctance to share
|
| 16 | information with authorities that don't have that track record and in whom they
|
| 17 | may not have as high a level of confidence in the protection of their
|
| 18 | information.
|
| 19 | And finally, I would note that although there have always been
|
| 20 | in my experience excellent protections with respect to confidentiality of the
|
| 21 | data, the differences in the way proceedings are handled do create certain
|
| 22 | suspicions and concerns on the part of parties who are involved. For example,
|
| 23 | in Europe it is far more commonplace for the regulators to articulate their |
49 |